Can a single model explain both breast cancer and prostate cancer?

Friedman AE.

Theor Biol Med Model. 2007 Aug 1;4:28. Review.

PMID: 17678531 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID: 17993229 [PubMed - indexed for MEDLINE]

Related Articles

[Hormones and growth of cancer]

Matsumoto K.

Nippon Naibunpi Gakkai Zasshi. 1992 Jun 20;68(6):577-83. Review. Japanese.

PMID: 1633928 [PubMed - indexed for MEDLINE]

Related Articles

Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer.

Kaseb AO, Chinnakannu K, Chen D, Sivanandam A, Tejwani S, Menon M, Dou QP, Reddy GP.

Cancer Res. 2007 Aug 15;67(16):7782-8.

PMID: 17699783 [PubMed - indexed for MEDLINE]

Related Articles

The 3rd Pacific Rim meeting on breast and prostate cancer: progress in hormonal carcinogenesis and the enduring influence of Ron Ross.

Reichardt JK, Tilley WD.

Cancer Res. 2007 May 15;67(10):4550-2. No abstract available.

PMID: 17510379 [PubMed - indexed for MEDLINE]

Related Articles

PC-1/PrLZ contributes to malignant progression in prostate cancer.

Zhang H, Wang J, Pang B, Liang RX, Li S, Huang PT, Wang R, Chung LW, Zhau HE, Huang C, Zhou JG.

Cancer Res. 2007 Sep 15;67(18):8906-13.

PMID: 17875733 [PubMed - indexed for MEDLINE]

Related Articles

Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.

He D, Falany CN.

Prostate. 2007 Sep 1;67(12):1318-29.

PMID: 17626250 [PubMed - indexed for MEDLINE]

Related Articles

Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.

Lee SO, Dutt SS, Nadiminty N, Pinder E, Liao H, Gao AC.

Prostate. 2007 Sep 1;67(12):1293-300.

PMID: 17626246 [PubMed - indexed for MEDLINE]

Related Articles

The Estradiol-Dihydrotestosterone model of prostate cancer.

Friedman AE.

Theor Biol Med Model. 2005 Mar 18;2:10.

PMID: 15777479 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines.

Bergner CC, Krause FS, Zugor V, Rith T, Schrott KM, Endele S, Engehausen DG.

Anticancer Res. 2007 Jul-Aug;27(4A):2071-4.

PMID: 17649823 [PubMed - indexed for MEDLINE]

Related Articles

Hormone refractory prostate cancer: Lessons learned from the PTEN prostate cancer model.

Mulholland DJ, Jiao J, Wu H.

Adv Exp Med Biol. 2008;617:87-95. Review. No abstract available.

PMID: 18497033 [PubMed - indexed for MEDLINE]

Related Articles

Effects of a phytoestrogen-containing soy extract on the growth-inhibitory activity of ICI 182 780 in an experimental model of estrogen-dependent breast cancer.

Gallo D, Mantuano E, Fabrizi M, Ferlini C, Mozzetti S, De Stefano I, Scambia G.

Endocr Relat Cancer. 2007 Jun;14(2):317-24.

PMID: 17639047 [PubMed - indexed for MEDLINE]

Related Articles

Platinum(II) complexes interfering with testicular steroid biosynthesis: drugs for the therapy of advanced or recurrent prostate cancers? Preclinical studies.

Schertl S, Hartmann RW, Batzl-Hartmann C, Spruss T, Maucher A, von Angerer E, Schiller CD, Schneider MR, Gust R, Schönenberger H.

J Cancer Res Clin Oncol. 2007 Mar;133(3):153-67. Epub 2006 Oct 6.

PMID: 17024493 [PubMed - indexed for MEDLINE]

Related Articles

Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer.

Shao TC, Li H, Ittmann M, Cunningham GR.

J Urol. 2007 Oct;178(4 Pt 1):1521-7. Epub 2007 Aug 16.

PMID: 17707058 [PubMed - indexed for MEDLINE]

Related Articles

Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells.

Kassi E, Papoutsi Z, Pratsinis H, Aligiannis N, Manoussakis M, Moutsatsou P.

J Cancer Res Clin Oncol. 2007 Jul;133(7):493-500. Epub 2007 Feb 15.

PMID: 17516089 [PubMed - indexed for MEDLINE]

Related Articles

The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts.

Dumont P, Ingrassia L, Rouzeau S, Ribaucour F, Thomas S, Roland I, Darro F, Lefranc F, Kiss R.

Neoplasia. 2007 Sep;9(9):766-76.

PMID: 17898872 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.

Yuli C, Shao N, Rao R, Aysola P, Reddy V, Oprea-llies G, Lee L, Okoli J, Partridge E, Reddy ES, Rao VN.

Oncogene. 2007 Sep 6;26(41):6031-7. Epub 2007 Mar 26.

PMID: 17384678 [PubMed - indexed for MEDLINE]

Related Articles

Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.

Gill C, Walsh SE, Morrissey C, Fitzpatrick JM, Watson RW.

Prostate. 2007 Nov 1;67(15):1641-53.

PMID: 17823925 [PubMed - indexed for MEDLINE]

Related Articles

The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.

Morgan C, Lewis PD, Jones RM, Bertelli G, Thomas GA, Leonard RC.

Acta Oncol. 2007;46(5):669-77.

PMID: 17562444 [PubMed - indexed for MEDLINE]

Related Articles

TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.

Woodfield GW, Horan AD, Chen Y, Weigel RJ.

Cancer Res. 2007 Sep 15;67(18):8439-43.

PMID: 17875680 [PubMed - indexed for MEDLINE]

Related Articles